New Axiom LLC – Trademark Portfolio

Entity Type: 16

New Axiom LLC holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 32 (Light Beverages) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include DIAMETRIC and AXIOM NUTRITION. The owner is based in Lee's Summit, MO.

949 NE Columbus St.

Lee's Summit, MO 64086

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

New Axiom LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

32
Light Beverages (1 filing)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

33
Wine & Spirits (1 filing)

Alcoholic beverages (except beers)

Frequently Asked Questions

How many trademarks does New Axiom LLC have?

New Axiom LLC has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does New Axiom LLC file in?

New Axiom LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 32 (Light Beverages), Class 5 (Pharmaceuticals), Class 33 (Wine & Spirits). Class 32 covers beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages.

What are New Axiom LLC's most well-known trademarks?

New Axiom LLC's registered trademark portfolio includes well-known marks such as DIAMETRIC and AXIOM NUTRITION. These are among 2 currently registered trademarks in the portfolio.

What is New Axiom LLC's trademark registration success rate?

New Axiom LLC has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.